Marcus Dahlman

Marcus Dahlman has a strong background in market access and consulting. Marcus started their career as a Management Consultant at IMPAC® Integrated Control Systems, Inc. in 1997 and later moved on to work as a Management Consultant at Resco AB from 1999 to 2001. Marcus then joined Destinct Consulting AB as a Strategy Consultant from 2001 to 2003. Following this, they worked at Dahlman Consulting as a Consultant from 2003 to 2006.

In 2006, Marcus joined Biogen Idec where they held various roles including Senior Health Economics Manager in the Nordic region from 2006 to 2012, and Associate Director, Global Market Access (Region Europe+) from 2012 to 2015.

From 2015 to 2019, Marcus worked at Teva Pharmaceuticals as the Nordic Head of Market Access until 2019 and also served as the Market Access Director from 2018 to 2019.

Currently, Marcus is the Head of Market Access Europe at Hansa Biopharma AB (publ), a position they have held since July 2019.

Marcus Dahlman attended the European School of Health Economics in 2008. Marcus did not obtain a degree or specialize in any particular field during this time. In 2007, they studied Advanced Methods for Cost-Effectiveness Analysis at the University of York, focusing on the Socio Economic Evaluation of Medicines. From 1997 to 1998, they pursued an MBA at Abertay University, concentrating on International Business, Marketing, and IT. Prior to that, from 1991 to 1995, Marcus completed a BSc in Business Administration at Lund University, specializing in Marketing and Organization. No information is available regarding their educational experiences before that.